Cencora Shares Outstanding 2010-2024 | COR
Cencora shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Cencora shares outstanding for the quarter ending September 30, 2024 were 0.198B, a 3.18% decline year-over-year.
- Cencora 2024 shares outstanding were 0.2B, a 2.11% decline from 2023.
- Cencora 2023 shares outstanding were 0.205B, a 3.13% decline from 2022.
- Cencora 2022 shares outstanding were 0.211B, a 1.32% increase from 2021.
| Cencora Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 200 |
| 2023 | 205 |
| 2022 | 211 |
| 2021 | 208 |
| 2020 | 205 |
| 2019 | 212 |
| 2018 | 220 |
| 2017 | 222 |
| 2016 | 226 |
| 2015 | 218 |
| 2014 | 235 |
| 2013 | 235 |
| 2012 | 257 |
| 2011 | 278 |
| 2010 | 287 |
| 2009 | 303 |
| Cencora Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-09-30 | 198 |
| 2024-06-30 | 200 |
| 2024-03-31 | 201 |
| 2023-12-31 | 202 |
| 2023-09-30 | 205 |
| 2023-06-30 | 204 |
| 2023-03-31 | 204 |
| 2022-12-31 | 206 |
| 2022-09-30 | 211 |
| 2022-06-30 | 212 |
| 2022-03-31 | 212 |
| 2021-12-31 | 211 |
| 2021-09-30 | 208 |
| 2021-06-30 | 209 |
| 2021-03-31 | 207 |
| 2020-12-31 | 207 |
| 2020-09-30 | 205 |
| 2020-06-30 | 206 |
| 2020-03-31 | 207 |
| 2019-12-31 | 208 |
| 2019-09-30 | 212 |
| 2019-06-30 | 211 |
| 2019-03-31 | 213 |
| 2018-12-31 | 214 |
| 2018-09-30 | 220 |
| 2018-06-30 | 221 |
| 2018-03-31 | 222 |
| 2017-12-31 | 221 |
| 2017-09-30 | 222 |
| 2017-06-30 | 222 |
| 2017-03-31 | 221 |
| 2016-12-31 | 222 |
| 2016-09-30 | 226 |
| 2016-06-30 | 225 |
| 2016-03-31 | 225 |
| 2015-12-31 | 227 |
| 2015-09-30 | 218 |
| 2015-06-30 | 240 |
| 2015-03-31 | 220 |
| 2014-12-31 | 219 |
| 2014-09-30 | 235 |
| 2014-06-30 | 226 |
| 2014-03-31 | 236 |
| 2013-12-31 | 237 |
| 2013-09-30 | 235 |
| 2013-06-30 | 236 |
| 2013-03-31 | 235 |
| 2012-12-31 | 236 |
| 2012-09-30 | 257 |
| 2012-06-30 | 256 |
| 2012-03-31 | 262 |
| 2011-12-31 | 263 |
| 2011-09-30 | 278 |
| 2011-06-30 | 279 |
| 2011-03-31 | 280 |
| 2010-12-31 | 281 |
| 2010-09-30 | 287 |
| 2010-06-30 | 287 |
| 2010-03-31 | 287 |
| 2009-12-31 | 291 |
| 2009-09-30 | 303 |
| 2009-06-30 | 301 |
| 2009-03-31 | 305 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $48.280B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $93.361B | 11.58 |
| DiDi Global (DIDIY) | China | $22.212B | 0.00 |
| Natera (NTRA) | United States | $22.082B | 0.00 |
| ICON (ICLR) | Ireland | $17.675B | 15.74 |
| Viatris (VTRS) | United States | $15.958B | 4.92 |
| Avantor (AVTR) | United States | $14.143B | 21.20 |
| Revvity (RVTY) | United States | $13.634B | 23.68 |
| CochLear (CHEOY) | Australia | $12.777B | 0.00 |
| Solventum (SOLV) | United States | $12.233B | 0.00 |
| BioMerieux (BMXMF) | France | $11.895B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.498B | 29.58 |
| Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
| HealthEquity (HQY) | United States | $9.104B | 49.41 |
| Doximity (DOCS) | United States | $8.999B | 52.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
| Life Times (LTH) | United States | $5.081B | 33.63 |
| Organon (OGN) | United States | $3.935B | 3.97 |
| Sotera Health (SHC) | United States | $3.631B | 19.42 |
| BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
| Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
| Concentras Parent (CON) | United States | $2.789B | 0.00 |
| PACS (PACS) | United States | $2.515B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
| Premier (PINC) | United States | $2.195B | 11.42 |
| GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
| Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
| Progyny (PGNY) | United States | $1.315B | 26.62 |
| Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
| CareDx (CDNA) | United States | $1.241B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
| Embecta (EMBC) | United States | $0.797B | 5.32 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| Agilon Health (AGL) | United States | $0.779B | 0.00 |
| SBC Medicals (SBC) | United States | $0.674B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| DocGo (DCGO) | United States | $0.434B | 16.35 |
| Enhabit (EHAB) | United States | $0.380B | 32.87 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
| ModivCare (MODV) | United States | $0.254B | 13.79 |
| LifeMD (LFMD) | United States | $0.251B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
| Biodesix (BDSX) | United States | $0.186B | 0.00 |
| Nutex Health (NUTX) | United States | $0.179B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| MultiPlan (MPLN) | United States | $0.112B | 0.00 |
| So-Young (SY) | China | $0.086B | 16.60 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.10 |
| IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
| Oncology Institute (TOI) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |